These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

313 related items for PubMed ID: 15951399

  • 21. SB-399885 is a potent, selective 5-HT6 receptor antagonist with cognitive enhancing properties in aged rat water maze and novel object recognition models.
    Hirst WD, Stean TO, Rogers DC, Sunter D, Pugh P, Moss SF, Bromidge SM, Riley G, Smith DR, Bartlett S, Heidbreder CA, Atkins AR, Lacroix LP, Dawson LA, Foley AG, Regan CM, Upton N.
    Eur J Pharmacol; 2006 Dec 28; 553(1-3):109-19. PubMed ID: 17069795
    [Abstract] [Full Text] [Related]

  • 22. WAY 100635 produces discriminative stimulus effects in rats mediated by dopamine D(4) receptor activation.
    Marona-Lewicka D, Nichols DE.
    Behav Pharmacol; 2009 Feb 28; 20(1):114-8. PubMed ID: 19179855
    [Abstract] [Full Text] [Related]

  • 23. Hippocampus 5-HT(1A)-receptors attenuate cocaine-induced hyperlocomotion and the increase in hippocampal but not nucleus accumbens 5-HT.
    Müller CP, Thönnessen H, Barros M, Tomaz C, Carey RJ, Huston JP.
    Hippocampus; 2004 Feb 28; 14(6):710-21. PubMed ID: 15318330
    [Abstract] [Full Text] [Related]

  • 24. Roles of 5-hydroxytryptamine (5-HT) receptor subtypes in the inhibitory effects of 5-HT on C-fiber responses of spinal wide dynamic range neurons in rats.
    Liu FY, Xing GG, Qu XX, Xu IS, Han JS, Wan Y.
    J Pharmacol Exp Ther; 2007 Jun 28; 321(3):1046-53. PubMed ID: 17329553
    [Abstract] [Full Text] [Related]

  • 25. Prolonged corticosterone treatment alters the responsiveness of 5-HT1A receptors to 8-OH-DPAT in rat CA1 hippocampal neurons.
    Czyrak A, Maćkowiak M, Chocyk A, Fijał K, Tokarski K, Bijak M, Wedzony K.
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Oct 28; 366(4):357-67. PubMed ID: 12237750
    [Abstract] [Full Text] [Related]

  • 26. Single exposure to a serotonin 1A receptor agonist, (+)8-hydroxy-2-(di-n-propylamino)-tetralin, produces a prolonged heterologous desensitization of serotonin 2A receptors in neuroendocrine neurons in vivo.
    Carrasco GA, Van de Kar LD, Jia C, Xu H, Chen Z, Chadda R, Garcia F, Muma NA, Battaglia G.
    J Pharmacol Exp Ther; 2007 Mar 28; 320(3):1078-86. PubMed ID: 17159160
    [Abstract] [Full Text] [Related]

  • 27. Central 5-HT3 receptor-induced hypothermia in mice: interstrain differences and comparison with hypothermia mediated via 5-HT1A receptor.
    Naumenko VS, Kondaurova EM, Popova NK.
    Neurosci Lett; 2009 Nov 06; 465(1):50-4. PubMed ID: 19735696
    [Abstract] [Full Text] [Related]

  • 28. Bidirectional modulation of classical fear conditioning in mice by 5-HT(1A) receptor ligands with contrasting intrinsic activities.
    Youn J, Misane I, Eriksson TM, Millan MJ, Ogren SO, Verhage M, Stiedl O.
    Neuropharmacology; 2009 Nov 06; 57(5-6):567-76. PubMed ID: 19607850
    [Abstract] [Full Text] [Related]

  • 29. Repeated adolescent 3,4-methylenedioxymethamphetamine (MDMA) exposure in rats attenuates the effects of a subsequent challenge with MDMA or a 5-hydroxytryptamine(1A) receptor agonist.
    Piper BJ, Vu HL, Safain MG, Oliver AJ, Meyer JS.
    J Pharmacol Exp Ther; 2006 May 06; 317(2):838-49. PubMed ID: 16434566
    [Abstract] [Full Text] [Related]

  • 30. [Optimizing effect of the combined administration of 8-OH-DPAT and galantamine on depression--anxiety behavior in old rats with dementia of Alzheimer's type].
    Sapronov NS, Fedotova IuO, Losev NA.
    Eksp Klin Farmakol; 2006 May 06; 69(3):10-3. PubMed ID: 16878490
    [Abstract] [Full Text] [Related]

  • 31. [8-OH-DPAT modulates expression of 5-HT(1A)/5-HT(2A), 17beta-estradiol receptor mRNAs in ovariectomized rats in Porsolt test].
    Fedotova IuO, Platonova NA, Sapronov NS.
    Eksp Klin Farmakol; 2006 May 06; 69(3):53-7. PubMed ID: 16878502
    [Abstract] [Full Text] [Related]

  • 32. Analysis of the role of 5-HT1A receptors in spatial and aversive learning in the rat.
    Lüttgen M, Elvander E, Madjid N, Ogren SO.
    Neuropharmacology; 2005 May 06; 48(6):830-52. PubMed ID: 15829255
    [Abstract] [Full Text] [Related]

  • 33. In vitro profile of the antidepressant candidate OPC-14523 at rat and human 5-HT1A receptors.
    Jordan S, Chen R, Koprivica V, Hamilton R, Whitehead RE, Tottori K, Kikuchi T.
    Eur J Pharmacol; 2005 Jul 11; 517(3):165-73. PubMed ID: 15985260
    [Abstract] [Full Text] [Related]

  • 34. 5-HT1A receptor-mediated G protein activation assessed by [35S]GTPgammaS binding in rat cerebral cortex.
    Odagaki Y, Toyoshima R.
    Eur J Pharmacol; 2005 Oct 03; 521(1-3):49-58. PubMed ID: 16182280
    [Abstract] [Full Text] [Related]

  • 35. The 5-HT(1A) receptor active compounds (R)-8-OH-DPAT and (S)-UH-301 modulate auditory evoked EEG responses in rats.
    Stevens KE, O'Neill HC, Rose GM, Luthman J.
    Amino Acids; 2006 Nov 03; 31(4):365-75. PubMed ID: 16868646
    [Abstract] [Full Text] [Related]

  • 36. Effect of WAY-100135 on the hippocampal acetylcholine release potentiated by 8-OH-DPAT, a serotonin1A receptor agonist, in normal and p-chlorophenylalanine-treated rats as measured by in vivo microdialysis.
    Nakai K, Fujii T, Fujimoto K, Suzuki T, Kawashima K.
    Neurosci Res; 1998 May 03; 31(1):23-9. PubMed ID: 9704975
    [Abstract] [Full Text] [Related]

  • 37. Role of spinal 5-HT(1A) receptors in morphine analgesia and tolerance in rats.
    Bardin L, Colpaert FC.
    Eur J Pain; 2004 Jun 03; 8(3):253-61. PubMed ID: 15109976
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Pharmacological properties of 3-amino-5,6,7,8-tetrahydro-2-[4-[4-(quinolin-2-yl)piperazin-1-yl]butyl]quinazolin-4(3H)-one (TZB-30878), a novel therapeutic agent for diarrhea-predominant irritable bowel syndrome (IBS) and its effects on an experimental IBS model.
    Tamaoki S, Yamauchi Y, Nakano Y, Sakano S, Asagarasu A, Sato M.
    J Pharmacol Exp Ther; 2007 Sep 03; 322(3):1315-23. PubMed ID: 17540858
    [Abstract] [Full Text] [Related]

  • 40. Co-administration of fluoxetine and WAY100635 improves short-term memory function.
    Fernández-Pérez S, Pache DM, Sewell RD.
    Eur J Pharmacol; 2005 Oct 17; 522(1-3):78-83. PubMed ID: 16214127
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.